Geode Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

  • $1.26 Trillion
  • Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,427,630 shares of REGN stock, worth $1.47 Billion. This represents 0.14% of its overall portfolio holdings.

Number of Shares
2,427,630
Previous 2,272,261 6.84%
Holding current value
$1.47 Billion
Previous $2.39 Billion 27.61%
% of portfolio
0.14%
Previous 0.2%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$701.85 - $1046.91 $109 Million - $163 Million
155,369 Added 6.84%
2,427,630 $1.73 Billion
Q3 2024

Nov 12, 2024
SELL
$1024.09 - $1201.76 $147 Million - $172 Million
-143,089 Reduced 5.92%
2,272,261 $2.39 Billion
Q2 2024

Aug 09, 2024
BUY
$883.2 - $1071.19 $34.2 Million - $41.5 Million
38,759 Added 1.63%
2,415,350 $2.54 Billion
Q1 2024

May 13, 2024
BUY
$902.69 - $993.35 $20.2 Million - $22.2 Million
22,374 Added 0.95%
2,376,591 $2.29 Billion
Q4 2023

Feb 13, 2024
BUY
$775.18 - $881.7 $26.5 Million - $30.2 Million
34,231 Added 1.48%
2,354,217 $2.07 Billion
Q3 2023

Nov 13, 2023
BUY
$692.45 - $844.37 $26.9 Million - $32.8 Million
38,857 Added 1.7%
2,319,986 $1.91 Billion
Q2 2023

Aug 11, 2023
BUY
$700.03 - $830.35 $44.2 Million - $52.4 Million
63,136 Added 2.85%
2,281,129 $1.64 Billion
Q1 2023

May 15, 2023
BUY
$680.49 - $826.97 $6.81 Million - $8.27 Million
10,003 Added 0.45%
2,217,993 $1.82 Billion
Q4 2022

Feb 13, 2023
SELL
$705.89 - $766.39 $22.7 Million - $24.6 Million
-32,123 Reduced 1.43%
2,207,990 $1.59 Billion
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $14.9 Million - $18.8 Million
26,009 Added 1.17%
2,240,113 $1.54 Billion
Q2 2022

Aug 12, 2022
BUY
$548.35 - $738.84 $66.5 Million - $89.6 Million
121,333 Added 5.8%
2,214,104 $1.31 Billion
Q1 2022

May 13, 2022
BUY
$595.12 - $698.43 $68.7 Million - $80.6 Million
115,469 Added 5.84%
2,092,771 $1.46 Billion
Q4 2021

Feb 11, 2022
BUY
$543.48 - $670.97 $129 Million - $159 Million
237,090 Added 13.62%
1,977,302 $1.25 Billion
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $18.5 Million - $21.9 Million
32,212 Added 1.89%
1,740,212 $1.05 Billion
Q2 2021

Aug 13, 2021
BUY
$472.8 - $558.54 $46.2 Million - $54.6 Million
97,810 Added 6.07%
1,708,000 $951 Million
Q1 2021

May 12, 2021
BUY
$446.73 - $548.2 $10.4 Million - $12.8 Million
23,271 Added 1.47%
1,610,190 $760 Million
Q4 2020

Feb 12, 2021
SELL
$478.3 - $607.98 $81.3 Million - $103 Million
-170,067 Reduced 9.68%
1,586,919 $765 Million
Q3 2020

Nov 13, 2020
BUY
$544.75 - $658.21 $128 Million - $155 Million
235,853 Added 15.51%
1,756,986 $982 Million
Q2 2020

Aug 13, 2020
BUY
$493.32 - $643.92 $93 Million - $121 Million
188,616 Added 14.15%
1,521,133 $947 Million
Q1 2020

May 14, 2020
BUY
$336.18 - $494.43 $22.1 Million - $32.5 Million
65,789 Added 5.19%
1,332,517 $649 Million
Q4 2019

Feb 13, 2020
BUY
$274.13 - $376.51 $6.9 Million - $9.47 Million
25,165 Added 2.03%
1,266,728 $475 Million
Q3 2019

Nov 12, 2019
BUY
$273.46 - $318.39 $22.2 Million - $25.8 Million
81,002 Added 6.98%
1,241,563 $344 Million
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $18.8 Million - $26 Million
62,713 Added 5.71%
1,160,561 $363 Million
Q1 2019

May 14, 2019
BUY
$372.08 - $439.57 $7.22 Million - $8.53 Million
19,395 Added 1.8%
1,097,848 $450 Million
Q4 2018

Feb 13, 2019
BUY
$335.82 - $403.04 $26.2 Million - $31.5 Million
78,143 Added 7.81%
1,078,453 $402 Million
Q3 2018

Nov 13, 2018
BUY
$351.14 - $408.51 $10.4 Million - $12 Million
29,493 Added 3.04%
1,000,310 $403 Million
Q2 2018

Aug 14, 2018
BUY
$284.6 - $344.99 $9.92 Million - $12 Million
34,841 Added 3.72%
970,817 $334 Million
Q1 2018

May 15, 2018
BUY
$315.82 - $393.78 $17.5 Million - $21.9 Million
55,495 Added 6.3%
935,976 $322 Million
Q4 2017

Feb 13, 2018
BUY
$358.63 - $469.95 $11 Million - $14.4 Million
30,581 Added 3.6%
880,481 $330 Million
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $8.8 Million - $10.3 Million
20,395 Added 2.46%
849,900 $379 Million
Q2 2017

Aug 14, 2017
BUY
N/A
829,505
829,505 $407 Million

Others Institutions Holding REGN

# of Institutions
1,470
Shares Held
88M
Call Options Held
1.15M
Put Options Held
1.39M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $64.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email